Showing results (681-690 of 3,073) with videos related to
Sort By:
Pageof 308
Pharmacological Reports : PR|January 8, 2025
Intranasal amyloid model of Alzheimer's disease - potential opportunities and challengesRakesh Kumar SinghPharmacological Reports : PR|January 14, 2025
Efficacy of probiotic adjuvant therapy in women with major depressive disorder: insights from a case series studyJairo Izidro Rossetti Navarro Júnior, Rafaela Aires, Thiago Antonio de Sousa Cutrim, et al.Pharmacological Reports : PR|September 5, 2024
Fiber photometry in neuroscience research: principles, applications, and future directionsMichal Kielbinski, Joanna BernackaPharmacological Reports : PR|September 2, 2024
The quest for optimal ketamine dosing formula in treatment-resistant major depressive disorderJulia Kwaśna, Wiesław Jerzy Cubała, Aleksander Kwaśny, et al.Pharmacological Reports : PR|September 11, 2024
Disrupted glutamate homeostasis as a target for glioma therapyMikołaj Biegański, Monika SzeligaPharmacological Reports : PR|August 20, 2024
The possible pathogenesis of liver fibrosis: therapeutic potential of natural polyphenolsChengu Niu, Jing Zhang, Patrick I OkoloPharmacological Reports : PR|August 23, 2024
Nicorandil antiallodynic activity in a model of neuropathic pain is associated with the activation of ATP-dependent potassium channels and opioidergic pathways, and reduced production of cytokines and neutrophils recruitment in paw, sciatic nerve, and dorsal root gangliaAlysson V Braga, Marcela Í Morais, Darly G S Delfino, et al.Pharmacological Reports : PR|November 17, 2024
ONC206, an imipridone derivative, demonstrates anti-colorectal cancer activity against stem/progenitor cells in 3D cell cultures and in patient-derived organoidsAlissar Monzer, Fatima Ghamlouche, Kevork Wakimian, et al.Pharmacological Reports : PR|November 2, 2024
Activation of 5-HT7 receptors in the mouse dentate gyrus does not affect theta-burst-induced plasticity at the perforant path synapseMarcin Siwiec, Bartosz Bobula, Michal Kielbinski, et al.Pharmacological Reports : PR|August 18, 2024
Effect of 28 days treatment of baricitinib on mechanical allodynia, osteopenia, and loss of nerve fibers in an experimental model of type-1 diabetes mellitusRosa I Acosta-González, Angélica Y Hernández-Jiménez, Laura Y Ramírez-Quintanilla, et al.Pageof 308